Product logins

Find logins to all Clarivate products below.


Dana Edwards

Senior Vice President, Sales and Marketing

Dana Edwards is the Senior Vice President of Sales and Marketing at Clarivate, where she leads global sales, commercial strategy, sales enablement, sales operations and marketing for the company’s Life Science and Healthcare portfolios.

With over two decades of experience, Dana has held leadership roles across the full spectrum of the life sciences ecosystem—including sponsors/pharma manufacturers, clinical research sites, CROs, and eClinical technology providers. Her career includes 8.5 years at IQVIA (formerly IMS Health), where she helped shape commercial strategies and drive growth across global markets.

Dana’s experience spans molecule to market, making her one of the few commercial executives with such a broad, cross-vertical perspective. She is known for her ability to align sales and marketing functions to deliver measurable impact, foster long-term client relationships, and support innovation through data-driven decision-making.

Her leadership is defined by a deep understanding of customer needs, a passion for collaboration, and a commitment to delivering value across the entire product lifecycle.

Dana holds a Bachelor of Science in Biochemistry from the University of North Carolina at Chapel Hill.

Latest news

News July 29, 2026
Clarivate Appoints Michael Easton as Chief Financial Officer

Experienced Clarivate leader brings more than 25 years of financial and operational expertise ​LONDON, July 29, 2026: Clarivate Plc (NYSE: CLVT) (“Clarivate” or the “Company”), a leading global provider of transformative intelligence, today…

News July 29, 2026
Clarivate Reports Second Quarter 2026 Results

— Delivers continued progress on strategic and financial priorities through Value Creation Plan — — Sharpens focus and enhances financial profile with previously announced Life Sciences & Healthcare segment divestiture…

News July 20, 2026
Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers

Prestigious awards program recognizes innovative AI technology transforming trademark risk assessment for legal professionals London, U.K. July, 20, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today…

Related resources

Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Biopharma Biotech Clinical trials CMC Development R&D Real-World Data Regulatory Research Safety
Three uncomfortable truths about cell and gene therapy in regulatory affairs Three uncomfortable truths about cell and gene therapy in regulatory affairs
Blog May 28, 2026
Three uncomfortable truths about cell and gene therapy in regulatory affairs
Consulting Resource Center Regulatory
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.